HDMA’s primary full-service healthcare distributors are responding to the emerging H1N1 influenza A virus public health situation. Distributors are working with the Centers for Disease Control and Prevention, other government agencies and manufacturers to ensure that antiviral and other medical products are available to meet pharmacy, physician and hospital demand. Read more >
For HDMA members’ role in antiviral and medical products distribution,
including a contact list for state public health officials
of HDMA member contacts, click here. |
|
| |
|
On January 7, HDMA announced changes to the structure of its senior leadership team. Ann W. Bittman has been promoted to the role of HDMA’s Executive Vice President and Chief Operating Officer. Additionally, the association introduced Brooke N. Naylor as its new Vice President for Meetings and Conferences, and two members of the organization’s senior leadership will assume increased roles. Read More > |
| |
|
John M. Gray, President and Chief Executive Officer of the Healthcare Distribution Management Association (HDMA), issued the following statement in reaction to Senate Amendment 2793 to the Patient Protection and Affordable Care Act, which would allow for importation of prescription medications: “Importation of prescription drugs from foreign countries, as Senator Dorgan and others propose to allow, would compromise the secure U.S. distribution system by increasing the likelihood of entry for counterfeit or adulterated medicines. Efforts to sell counterfeit or adulterated medications produced overseas have become far more sophisticated in just the past few years."Read More >
|
| |
|
| |
 |
Center for Healthcare Supply Chain Research Issues New Publication Featuring Specialty Pharmaceutical Segment
DIANA, Nexus and Power of Partnership Awards
Presented at 2009 Annual Leadership Forum
Healthcare Distributors Stand Ready to Work with State Governments to Take On Influenza Pandemic Challenge |
| |
|
|
